Chai Discovery platform
Molecular structure prediction and design tools for antibody and protein engineering.
Find alternatives to Chai Discovery platform
What it does
- Drug discovery
Features 6
- Epitope-specific designChoose an epitope on the target structure, or let the model choose.
- Antigen-state targetingDesigns explicitly for agonism or antagonism by targeting a specific antigen state.
- Miniprotein binder designChai-2 designs miniprotein binders with a 68% wet-lab hit rate.
- Full-length mAb designDesigns full-length, drug-like monoclonal antibodies.
- Single-sequence modeChai-1 can run without multiple sequence alignments while preserving most of its performance.
- Epitope conditioningUses a few contacts or pocket residues to double antibody-antigen structure prediction accuracy.
Sources
- Sold within
-
"We are opening up access to Chai-2 to commercial organizations. To schedule a call with our team, fill out the access form and we'll be in touch." Academic use is an early-access interest form. No price or self-serve signup is stated.
- Name
-
Official documentation · 21 Oct 2026
Nav label "Platform"; the page is about Chai-2 access: "We are opening up access to Chai-2 to commercial organizations."
- URL
-
Official documentation · 21 Oct 2026
Fetched 2026-10-21: HTTP 200; the nav calls it "Platform".
- Intended for
-
"Academic use — We'll be making Chai-2 available for limited non-commercial use"; access-request form lists Organization type: Commercial/Academic/Non-profit.
Open Chai Discovery in the directory
Something wrong here? Send a correction — quote this product id: chai-discovery-platform.